GGrantIndex
← Search

TRIAL OF NOVEL PEPTIDE PULSED DENDRITIC CELL VACCINE FOR MELANOMA TREATMENT

$0M01FY2000RRNIH

University Of Pennsylvania, Philadelphia PA

Investigators

Linked publications & trials

Abstract

You understand that you have been asked to participate in this research study because you have a diagnosis of metastataic melanoma. The purpose of this study is to: 1. determine the safety of the vaccine under investigation; and 2. determine how well the vaccine activates the immune system in patients with metastatic melanoma.

View original record on NIH RePORTER →